Patents by Inventor James Stephen Swaney

James Stephen Swaney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170114125
    Abstract: Methods for preventing or treating pain are provided, comprising administering to a subject, including a human subject, an antibody or antibody fragment that binds LPA.
    Type: Application
    Filed: October 23, 2016
    Publication date: April 27, 2017
    Inventors: Roger A. SABBADINI, Rosalia MATTEO, Genevieve HANSEN, William Arthur GARLAND, James Stephen SWANEY
  • Publication number: 20160152735
    Abstract: Compositions and methods for making and using anti-LPA agents, for example, monoclonal antibodies, are described. Variable domain and complementarity determining region amino acid sequences of several monoclonal antibodies against LPA are disclosed, as is a consensus anti-LPA monoclonal antibody variable domain sequence.
    Type: Application
    Filed: September 22, 2015
    Publication date: June 2, 2016
    Inventors: Roger A. SABBADINI, William A. GARLAND, Genevieve HANSEN, James Stephen SWANEY, Rosalia MATTEO, Gordon MILLS, Jonathan Michael WOJCIAK
  • Publication number: 20160146844
    Abstract: Compositions and methods for making and using anti-LPA agents, for example, monoclonal antibodies, are described.
    Type: Application
    Filed: July 29, 2015
    Publication date: May 26, 2016
    Inventors: Roger A. SABBADINI, Genevieve HANSEN, William Arthur GARLAND, James Stephen SWANEY
  • Patent number: 9163091
    Abstract: Compositions and methods for making and using anti-LPA agents, for example, monoclonal antibodies, are described. Variable domain and complementarity determining region amino acid sequences of several monoclonal antibodies against LPA are disclosed, as is a consensus anti-LPA monoclonal antibody variable domain sequence.
    Type: Grant
    Filed: March 18, 2009
    Date of Patent: October 20, 2015
    Assignee: Lpath, Inc.
    Inventors: Roger A. Sabbadini, William A. Garland, James Stephen Swaney, Rosalia Matteo, Gordon Mills, Jonathan Michael Wojciak
  • Publication number: 20130253019
    Abstract: Described herein is the use of LPA1 antagonists in the treatment or prevention of diseases or conditions of the eye of a mammal. Also described are pharmaceutical compositions that include at least one LPA1 antagonist.
    Type: Application
    Filed: June 13, 2011
    Publication date: September 26, 2013
    Inventors: John Howard Hutchinson, Thomas Jon Seiders, James Stephen Swaney
  • Publication number: 20120195901
    Abstract: Compositions and methods for making and using anti-LPA agents, for example, monoclonal antibodies, are described.
    Type: Application
    Filed: April 16, 2012
    Publication date: August 2, 2012
    Inventors: Roger A. SABBADINI, William A. GARLAND, Genevieve HANSEN, James Stephen SWANEY
  • Patent number: 8158124
    Abstract: Compositions and methods for making and using anti-LPA agents, for example, monoclonal antibodies, are described.
    Type: Grant
    Filed: May 29, 2008
    Date of Patent: April 17, 2012
    Assignee: Lpath, Inc.
    Inventors: Roger A. Sabbadini, William A. Garland, Genevieve Hansen, James Stephen Swaney
  • Publication number: 20100034814
    Abstract: Compositions and methods for making and using anti-LPA agents, for example, monoclonal antibodies, are described. Variable domain and complementarity determining region amino acid sequences of several monoclonal antibodies against LPA are disclosed, as is a consensus anti-LPA monoclonal antibody variable domain sequence.
    Type: Application
    Filed: March 18, 2009
    Publication date: February 11, 2010
    Inventors: Roger A. SABBADINI, William A. GARLAND, Genevieve HANSEN, James Stephen SWANEY, Rosalia MATTEO, Gordon MILLS, Jonathan Michael WOJCIAK
  • Publication number: 20090136483
    Abstract: Compositions and methods for making and using anti-LPA agents, for example, monoclonal antibodies, are described.
    Type: Application
    Filed: May 29, 2008
    Publication date: May 28, 2009
    Inventors: Roger A. SABBADINI, William A. Garland, Genevieve Hansen, James Stephen Swaney